Myelodysplastic Syndrome With Isolated del(5q) Coexisting With Cold Agglutinin Disease Presenting as Unexplained Hyperbilirubinemia.
- 1Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
- 2Hematology and Oncology, Ashtabula County Medical Center, Ashtabula, USA.
Abstract
Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia caused by cold-reactive IgM autoantibodies that activate the classical complement pathway. It is characteristically associated with clonal B-cell lymphoproliferative disorders, and its association with myelodysplastic syndrome (MDS) is rare. We report a 75-year-old woman evaluated over nine months for isolated, predominantly indirect hyperbilirubinemia attributed to hepatobiliary disease before hemolysis was recognized. An anti-IgG-only direct antiglobulin test (DAT) was negative, and she was referred as having Coombs-negative hemolytic anemia; a complement-inclusive DAT subsequently demonstrated polyspecific antiglobulin and anti-C3b/C3d positivity at 3+ with negative anti-IgG, with cold agglutinin titers above 1:1024 and low C4, confirming complement-mediated hemolysis. Recurrent specimen interference, including prewarming requirements and spuriously elevated mean corpuscular hemoglobin concentration, had been present for months. Bone marrow evaluation demonstrated MDS with isolated del(5q) alongside a small IgM-kappa monoclonal protein; to our knowledge, this coexistence has not previously been reported, although the source of the cold agglutinin was not established. After deterioration to a hemoglobin nadir of 7.3 g/dL, she received two units of packed red blood cells and the complement C1s inhibitor sutimlimab. Hemoglobin entered the reference range by day 33 and remained stable through day 103 without further transfusion, with near-normalization of lactate dehydrogenase and substantial improvement in bilirubin.
Related
- Severe Neonatal Hereditary Spherocytosis Presenting With Hyperbilirubinemia and Profound Anemia: A Case Report
- GATA2 Deficiency Presenting With a WHIM‐Like Phenotype and Subsequent Development of Monosomy 7‐Associated Myelodysplastic Syndrome in an Adolescent Female: A Case Report
- Coexisting left atrial myxoma-like mass and pulmonary vein metastatic component of adrenocortical carcinoma presenting with cardioembolic stroke: a case report
- Marked Monocytic Erythrophagocytosis in a Patient With Cold Agglutinin Disease.
- Sustained molecular clearance of the MYD88 p.L265P-mutant clone preceding resolution of cold agglutinin syndrome after autologous stem cell transplantation
BibTeX
@article{sheppard2026myelodysplastic,
title = {{Myelodysplastic Syndrome With Isolated del(5q) Coexisting With Cold Agglutinin Disease Presenting as Unexplained Hyperbilirubinemia.}},
author = {Madison N Sheppard and Lindsey Mayer and Shinoj Pattali Jayavalsan},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117773},
url = {https://europepmc.org/article/MED/43011965},
note = {CC BY},
}
RIS
TY - JOUR
TI - Myelodysplastic Syndrome With Isolated del(5q) Coexisting With Cold Agglutinin Disease Presenting as Unexplained Hyperbilirubinemia.
AU - Madison N Sheppard
AU - Lindsey Mayer
AU - Shinoj Pattali Jayavalsan
PY - 2026
DA - 2026/10/11
JO - Cureus
DO - 10.7759/cureus.117773
UR - https://europepmc.org/article/MED/43011965
AB - Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia caused by cold-reactive IgM autoantibodies that activate the classical complement pathway. It is characteristically associated with clonal B-cell lymphoproliferative disorders, and its association with myelodysplastic syndrome (MDS) is rare. We report a 75-year-old woman evaluated over nine months for isolated, predominantly indirect hyperbilirubinemia attributed to hepatobiliary disease before hemolysis was recognized. An anti-IgG-only direct antiglobulin test (DAT) was negative, and she was referred as having Coombs-negative hemolytic anemia; a complement-inclusive DAT subsequently demonstrated polyspecific antiglobulin and anti-C3b/C3d positivity at 3+ with negative anti-IgG, with cold agglutinin titers above 1:1024 and low C4, confirming complement-mediated hemolysis. Recurrent specimen interference, including prewarming requirements and spuriously elevated mean corpuscular hemoglobin concentration, had been present for months. Bone marrow evaluation demonstrated MDS with isolated del(5q) alongside a small IgM-kappa monoclonal protein; to our knowledge, this coexistence has not previously been reported, although the source of the cold agglutinin was not established. After deterioration to a hemoglobin nadir of 7.3 g/dL, she received two units of packed red blood cells and the complement C1s inhibitor sutimlimab. Hemoglobin entered the reference range by day 33 and remained stable through day 103 without further transfusion, with near-normalization of lactate dehydrogenase and substantial improvement in bilirubin.
SN - 2168-8184
ER -